FDA News Releases published a clinical update in Research Highlights on 15 Jun 2026. The item focuses on FDA Approves New Indication for Tzield (teplizumab) for Certain Pediatric Patients with Recently Diagnosed Stage 3 Type 1 Diabetes. Open the detail page to review the full original feed content.